DENTSPLY SIRONA Inc. (XRAY)
| Market Cap | 1.95B -25.5% |
| Revenue (ttm) | 3.64B -0.8% |
| Net Income | -546.00M |
| EPS | -2.73 |
| Shares Out | 199.35M |
| PE Ratio | n/a |
| Forward PE | 6.40 |
| Dividend | $0.32 (3.24%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 1,137,751 |
| Open | 9.66 |
| Previous Close | 9.44 |
| Day's Range | 9.65 - 9.93 |
| 52-Week Range | 9.36 - 14.76 |
| Beta | 0.85 |
| Analysts | Hold |
| Price Target | 13.53 (+37.99%) |
| Earnings Date | Nov 5, 2026 |
About XRAY
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as w... [Read more]
Financial Performance
In 2025, DENTSPLY SIRONA's revenue was $3.68 billion, a decrease of -2.98% compared to the previous year's $3.79 billion. Losses were -$598.00 million, -34.29% less than in 2024.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for XRAY stock is "Hold." The 12-month stock price target is $13.53, which is an increase of 37.99% from the latest price.
News
DENTSPLY SIRONA Transcript: 2026 Global Healthcare Conference
Leadership highlighted ongoing transformation, resource reallocation, and a 24-month turnaround plan. Strategic focus includes expanding sales channels, investing in clinical education and R&D, and enhancing digital workflows. Financially, sequential EPS growth is targeted, with long-term goals of market-level or better growth and improved cash flow.
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global ...
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
"I'll give you 950 billion reasons to buy bonds right now," says Thomas Hayes, who gives a contrarian take on why investors should bolster their portfolios in fixed income. He discusses the "seasonali...
New At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary Incontinence
New system completes the Surity™ portfolio of external catheters for both men and women Integrates into daily routines to help support management of urinary incontinence at home Designed to operate q...
DENTSPLY SIRONA Earnings Call Transcript: Q2 2026
Q2 2026 revenue declined 4.1% as reported, with flat adjusted EPS and strong cash flow boosted by tariff refunds. The Return-to-Growth plan is progressing, with investments in commercial capabilities and innovation expected to drive improvement, especially in Q4.
DENTSPLY SIRONA Slides: Q2 2026
DENTSPLY SIRONA has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
DENTSPLY SIRONA Earnings release: Q2 2026
DENTSPLY SIRONA released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
DENTSPLY SIRONA Quarterly report: Q2 2026
DENTSPLY SIRONA has published its Q2 2026 quarterly earnings report on August 6, 2026.
Dentsply Sirona Reports Second Quarter 2026 Results
News Summary Reported net sales of $898 million Delivered GAAP gross margin of 54.9%, GAAP diluted earnings per share of $0.18 Achieved adjusted gross margin of 56.4%, adjusted EBITDA margin of 21.3%,...
Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship
CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its l...
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and l...
PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry
This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent...
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses Brings more than 25 years of experience leading transformation, capi...
DENTSPLY SIRONA Transcript: AGM 2026
The meeting, held virtually, covered four proposals including board elections, auditor ratification, executive compensation, and an incentive plan amendment. All proposals passed by majority vote, with no questions submitted by stockholders.
DENTSPLY SIRONA Transcript: Stifel Jaws & Paws Conference 2026
Leadership is driving organizational simplification, digital transformation, and expanded distribution, with restructuring savings reinvested in education, R&D, and commercial support. Sequential revenue improvement is targeted by late 2026, with division-specific strategies to regain share and drive growth through 2028.
Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets
CHARLOTTE, N.C., May 26, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the str...
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference
CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & P...
DENTSPLY SIRONA Earnings Call Transcript: Q1 2026
Q1 2026 results were in line with expectations, with revenue stable and early progress on cost savings and innovation. The company maintained its full-year outlook, focusing on restructuring, debt reduction, and new product launches, while monitoring macro risks and competitive pressures.
DENTSPLY SIRONA Earnings release: Q1 2026
DENTSPLY SIRONA released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
DENTSPLY SIRONA Slides: Q1 2026
DENTSPLY SIRONA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
DENTSPLY SIRONA Quarterly report: Q1 2026
DENTSPLY SIRONA has published its Q1 2026 quarterly earnings report on May 5, 2026.
Dentsply Sirona Reports First Quarter 2026 Results
News Summary Reported net sales of $880 million Delivered GAAP gross margin of 48.5% , GAAP net loss per share of ($0.05) Achieved adjusted gross margin of 50.7% , adjusted EBITDA margin of 14.7% , ad...
Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply
CHARLOTTE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced an enha...
DENTSPLY SIRONA Proxy statement: Proxy filing
DENTSPLY SIRONA filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.